Grinterol 250 mg hard capsules

Manufacturer
JOINT STOCK COMPANY GRINDEKS(LATVIA)

Registraction Number
MAL24116020AZ

Content:
Grinterol 250 mg hard capsules contain ursodeoxycholic acid 250 mg per capsule.
Indications:

• Dissolution of Cholesterol Gallstones: Treatment of radiolucent (X-ray negative) cholesterol gallstones no larger than 15 mm in diameter in patients with a functioning gallbladder.
• Biliary Reflux Gastritis: Treatment of biliary reflux gastritis.
• Primary Biliary Cirrhosis (PBC): Symptomatic treatment of primary biliary cirrhosis in the absence of decompensated liver cirrhosis.
• Hepatobiliary Disorders in Cystic Fibrosis: Treatment of hepatobiliary disorders in children aged 6 to 18 years with cystic fibrosis.

1. Dosage: The dosage is individualized based on the patient's condition and needs. Follow the prescribed regimen closely.
2. Administration: Take the capsule orally, with or without food.
3. Consistency: Take the medication at the same time each day.
4. Monitoring: Regular monitoring by a healthcare provider is essential to ensure effectiveness and adjust dosage if needed.